INCIDENCE OF ADVERSE-EFFECTS FOLLOWING METRIZAMIDE MYELOGRAPHY IN NON-AMBULATORY AND AMBULATORY PATIENTS

被引:41
作者
SYKES, RHD
WASENAAR, W
CLARK, P
机构
[1] PLAINS HLTH CTR,DEPT RADIOL,REGINA,SASKATCHEWAN,CANADA
[2] STERLING DRUG LTD,AURORA,ONTARIO,CANADA
[3] UNIV SASKATCHEWAN,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
关键词
D O I
10.1148/radiology.138.3.7465839
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:625 / 627
页数:3
相关论文
共 7 条
  • [1] ALPERS BJ, 1971, CLIN NEUROLOGY, P125
  • [2] BANNISTER R, 1973, CLIN NEUROLOGY, P114
  • [3] GELMERS HJ, 1979, NEURORADIOLOGY, V18, P119
  • [4] MACROBERT RG, 1918, JAMA, V17, P1350
  • [5] MERRITT HH, 1979, TXB NEUROLOGY, P415
  • [6] ROBERTSON WD, 1980, AM J NEURORADIOL, V1, P197
  • [7] Sinclair D J, 1972, J Can Assoc Radiol, V23, P278